FR2797272B1 - Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations - Google Patents

Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations

Info

Publication number
FR2797272B1
FR2797272B1 FR9910140A FR9910140A FR2797272B1 FR 2797272 B1 FR2797272 B1 FR 2797272B1 FR 9910140 A FR9910140 A FR 9910140A FR 9910140 A FR9910140 A FR 9910140A FR 2797272 B1 FR2797272 B1 FR 2797272B1
Authority
FR
France
Prior art keywords
compositions
new
methods
gene mutations
parkin gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9910140A
Other languages
English (en)
Other versions
FR2797272A1 (fr
Inventor
Alexis Brice
Christoph Luecking
Patrice Denefle
Sylvain Ricard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9910140A priority Critical patent/FR2797272B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to NZ512313A priority patent/NZ512313A/en
Priority to AU12769/00A priority patent/AU778281B2/en
Priority to IL14275599A priority patent/IL142755A0/xx
Priority to CA2996759A priority patent/CA2996759A1/fr
Priority to EP10184008A priority patent/EP2345722A1/fr
Priority to PT99956079T priority patent/PT1131424E/pt
Priority to EP99956079A priority patent/EP1131424B1/fr
Priority to EP10184027A priority patent/EP2311954A1/fr
Priority to US09/856,290 priority patent/US7998667B1/en
Priority to DK99956079T priority patent/DK1131424T3/da
Priority to EP10184042A priority patent/EP2305816A1/fr
Priority to DE69941300T priority patent/DE69941300D1/de
Priority to ES99956079T priority patent/ES2330281T3/es
Priority to EP09167384A priority patent/EP2128257A3/fr
Priority to CA2351567A priority patent/CA2351567C/fr
Priority to PCT/FR1999/002833 priority patent/WO2000031253A2/fr
Priority to CA2872581A priority patent/CA2872581C/fr
Priority to AT99956079T priority patent/ATE440138T1/de
Priority to JP2000584062A priority patent/JP5424519B2/ja
Publication of FR2797272A1 publication Critical patent/FR2797272A1/fr
Priority to IL142755A priority patent/IL142755A/en
Priority to NO20012342A priority patent/NO330896B1/no
Application granted granted Critical
Publication of FR2797272B1 publication Critical patent/FR2797272B1/fr
Priority to IL187652A priority patent/IL187652A/en
Priority to CY20091101178T priority patent/CY1110535T1/el
Priority to NO20110577A priority patent/NO332174B1/no
Priority to NO20110580A priority patent/NO333906B1/no
Priority to NO20110578A priority patent/NO332173B1/no
Priority to NO20110582A priority patent/NO333907B1/no
Priority to US13/209,495 priority patent/US8835618B2/en
Priority to US14/454,026 priority patent/US9540693B2/en
Priority to US15/343,323 priority patent/US20170183736A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9910140A 1998-11-19 1999-08-04 Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations Expired - Fee Related FR2797272B1 (fr)

Priority Applications (31)

Application Number Priority Date Filing Date Title
FR9910140A FR2797272B1 (fr) 1999-08-04 1999-08-04 Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations
AT99956079T ATE440138T1 (de) 1998-11-19 1999-11-18 Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen
IL14275599A IL142755A0 (en) 1998-11-19 1999-11-18 Mutation of the parkin gene, compositions, methods and uses
AU12769/00A AU778281B2 (en) 1998-11-19 1999-11-18 Mutation of the parkin gene, compositions, methods and uses
EP10184008A EP2345722A1 (fr) 1998-11-19 1999-11-18 Mutations du gêne de la parkine, compositions, méthodes et utilisations
JP2000584062A JP5424519B2 (ja) 1998-11-19 1999-11-18 パーキン遺伝子の突然変異、組成物、方法及び使用
EP99956079A EP1131424B1 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
EP10184027A EP2311954A1 (fr) 1998-11-19 1999-11-18 Mutations du gène de la Parkine, compositions, methodes et utilisations
US09/856,290 US7998667B1 (en) 1998-11-19 1999-11-18 Mutations of the parkin gene, compositions, methods and uses
DK99956079T DK1131424T3 (da) 1998-11-19 1999-11-18 Mutationer af Pakin-genet, sammensætninger, fremgangsmåder samt anvendelser
EP10184042A EP2305816A1 (fr) 1998-11-19 1999-11-18 Mutations du gène de la parkine, compositions, méthodes et utilisations
DE69941300T DE69941300D1 (de) 1998-11-19 1999-11-18 Fahren und verwendungen
ES99956079T ES2330281T3 (es) 1998-11-19 1999-11-18 Mutaciones del gen de la parquina, composiciones, metodos y usos.
EP09167384A EP2128257A3 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
CA2351567A CA2351567C (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
PCT/FR1999/002833 WO2000031253A2 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
NZ512313A NZ512313A (en) 1998-11-19 1999-11-18 Mutation of the parkin gene exoressed in the heterozygous state, compositions, methods and uses
CA2996759A CA2996759A1 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
PT99956079T PT1131424E (pt) 1998-11-19 1999-11-18 Mutações do gene da parkina, composições, métodos e utilizações
CA2872581A CA2872581C (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
IL142755A IL142755A (en) 1998-11-19 2001-04-23 Parkin gene nucleic acid with alterations expressed only at heterozygous state, vector and cell and non-human mammal comprising said acid, polypeptides encoded by said acid and methods for identifying said alterations
NO20012342A NO330896B1 (no) 1998-11-19 2001-05-11 Nukleinsyre som koder for en mutert form av h-parkin, polypeptid, antistoff,sammensetning, probe, fremgangsmater, vektor, celle, ikke-humant pattedyr samt anvendelser.
IL187652A IL187652A (en) 1998-11-19 2007-11-26 Antibody specific for a polypeptide encoded by the human parkin gene and a composition comprising it
CY20091101178T CY1110535T1 (el) 1998-11-19 2009-11-11 Μεταλλαξεις του γονιδιου της παρκινης, συνθεσεις, μεθοδοι και χρησεις
NO20110577A NO332174B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse
NO20110580A NO333906B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse
NO20110582A NO333907B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse.
NO20110578A NO332173B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse.
US13/209,495 US8835618B2 (en) 1998-11-19 2011-08-15 Mutations of the parkin gene
US14/454,026 US9540693B2 (en) 1998-11-19 2014-08-07 Mutations of the parkin gene, compositions, methods and uses
US15/343,323 US20170183736A1 (en) 1998-11-19 2016-11-04 Mutations of the parkin gene, compositions, methods and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910140A FR2797272B1 (fr) 1999-08-04 1999-08-04 Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations

Publications (2)

Publication Number Publication Date
FR2797272A1 FR2797272A1 (fr) 2001-02-09
FR2797272B1 true FR2797272B1 (fr) 2004-06-04

Family

ID=9548887

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9910140A Expired - Fee Related FR2797272B1 (fr) 1998-11-19 1999-08-04 Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations

Country Status (1)

Country Link
FR (1) FR2797272B1 (fr)

Also Published As

Publication number Publication date
FR2797272A1 (fr) 2001-02-09

Similar Documents

Publication Publication Date Title
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DE60138711D1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
DE60002893D1 (de) Computerplattformen und deren betriebsverfahren
IS6847A (is) Eterafleiður, nytsamlegar sem hindrar PDE4 samsætuensíma
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
NO20022334L (no) Ny sammensetning og anvendelse
DE60130043D1 (de) Grundierungszusammensetzung und Beschichtungsverfahren
NO20025450L (no) Ny farmasöytisk sammensetning
DE60018950D1 (de) Gegen zusammendrücken beständige wellschlauchverbindung
IS5944A (is) Azabísýklóalkön sem CCR5 stillar
DE60034683D1 (de) 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE60225204D1 (de) Polymerelektrolyt und Hestellungsverfahren dafür
ATE311432T1 (de) Stabile substanzen, zusammensetzungen und waschverfahren zu deren verwendung
ATE274542T1 (de) Amphiphile blockcopolymere
DE60215326D1 (de) Mischsystem und -verfahren
DE60028486D1 (de) Videocoder und -decoder
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
FR2831442B1 (fr) Composition cosmetique mimant le sebum, et utilisations
BR0008192B1 (pt) agente de emplastro no formato de folha.
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
DE60118910D1 (de) Phosphatkonversionsüberzugverfahren und zusammensetzung
NL1018865A1 (nl) Kathode en werkwijze voor de vervaardiging ervan.
FR2797272B1 (fr) Nouvelles mutations du gene de la parkine, compositions, methodes et utilisations
FI19992142A (fi) Vesineulattu kuitukangas, menetelmä sen valmistamiseksi ja sen käyttö

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20160429